|
End-of-day quote
Korea S.E.
2026-11-19
|
5-day change | 1st Jan Change | ||
| 1,876.00 KRW | +3.88% |
|
-9.37% | -59.96% |
| 09-20 | Genexine, Inc.(KOSDAQ:A095700) dropped from S&P Global BMI Index | CI |
| 09-15 | Genexine Presents Preclinical Data For GX-BP1 SOX2 BioPROTAC At 2026 World Conference On Lung Cancer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENEXINE, INC. | Bio Therapeutic Drugs | +3.88% | -9.37% | -59.96% | -61.12% | -96.00% | 61.62M |
- Stock Market
- Stocks
- A095700 Stock
- Charts Genexine, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















